NeuroScientific readies stem cell supply boost for bowel disease trials

NeuroScientific Biopharmaceuticals has ticked off another key box on the road to commercialising the company’s StemSmart stem cell therapy, kicking off its first manufacturing run at one of Australia’s leading cell therapy facilities in Brisbane.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.